Click image to enlarge
The U-PLEX Biomarker Group 3 Human 21-Plex is a panel of biomarkers (Table 1) that has been tested for multiplex compatibility and is fulfilled as a kit. It contains a mix of inflammatory biomarkers, metabolic markers, and emerging biomarkers that are related to other diseases. The assays can be used for quantitative measurements of the sample types listed in the "Specifications" tab below, and offer detection limits (LLODs) in the sub- to low pg/mL range.
Analyte | LLOD - ULOD | units |
A2M | 13.2 - 32,000 | pg/mL |
Adiponectin | 1.46 - 5,000 | pg/mL |
ApoA1 | 4.93 - 25,000 | pg/mL |
ApoC3 | 1.06 - 10,000 | pg/mL |
CA1 | 1.01 - 6,000 | pg/mL |
Clusterin | 57.7 - 500,000 | pg/mL |
Complement C9 | 10.3 - 70,000 | pg/mL |
Complement factor D | 0.31 - 3,000 | pg/mL |
CRP | 0.92 - 2,170 | pg/mL |
Cystatin C | 23.9 - 20,000 | pg/mL |
DPPIV | 0.85 - 7,000 | pg/mL |
Analyte | LLOD - ULOD | units |
Factor VII | 0.60 - 6,000 | pg/mL |
ICAM-1 | 0.11 - 1,930 | pg/mL |
NGAL/LCN2 | 0.78 - 4,000 | pg/mL |
RBP4 | 3.78 - 4,000 | pg/mL |
SAA | 1.60 - 16,200 | pg/mL |
Serpin A1 | 5.52 - 22,000 | pg/mL |
SHBG | 3.52 - 25,000 | pg/mL |
sTfR-1 | 0.29 - 3,000 | pg/mL |
VCAM-1 | 7.78 - 20,500 | pg/mL |
VWF | 67.4 - 100,0000 | pg/mL |
-
-
Specifications
-
-
Documentation
-
References
Analyte(s)
|
|
A2M, Adiponectin, ApoA1, ApoC3, CA1, Clusterin, Complement C9, Complement factor D, CRP, Cystatin C, DPPIV, Factor VII, ICAM-1, NGAL/LCN2, RBP4, SAA, Serpin A1, SHBG, sTfR-1, VCAM-1, vWF
|
|
Species
|
|
Human
|
|
Plate Type
|
|
96-well
|
|
U-PLEX Group Compatibility
|
|
Biomarker Group 3
|
|
Instrument(s)
|
|
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO QuickPlex SQ 120
,
SECTOR Imager 6000
,
SECTOR Imager 2400
|
|
Sample Type
|
|
Cell Culture Media, Plasma, Serum
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Inserts
|
|
|
Datasheets
|
|
View More
|
Product Highlights
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Effects of a Synbiotic on Symptoms, and Daily Functioning in Attention Deficit Hyperactivity Disorder - A Double-Blind Randomized Controlled Trial
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy.
|
|
|
|
Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.
|
|
|
|
Genetic Deletion and Pharmacological Inhibition of Phosphodiesterase 10A Protects Mice From Diet-Induced Obesity and Insulin Resistance.
|
|
|
|
View All
|
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters